CLINICL STUDY OF INFLAMMATORY BOWEL DISEASE WITH REFERENCE TO CRP, ESR, ALBUMIN

Dr. P. Srujan., Dr. K. Sreekanth

Abstract


Inflammatory bowel disease (IBD), which includes Crohn's disease and ulcerative colitis (UC), is a relapsing and remitting condition characterized by chronic inflammation at various sites in the GI tract, which results in diarrhea and abdominal pain.

Aims of the Study

The aim of the study the correlation of CRP, ESR, ALBUMIN in relation to the disease activity of IBD.

Material & Methods

Patients who come to the outpatient department of general medicine and gastroenterology as well as to the emergency department are taken up for the study.

Results

A total of 47 cases are studied, Out of 47 cases, 42 (89.36%) are ulcerative colitis 5 (10.63%) are crohn’s disease.


Keywords


Inflammatory Bowel Disease, CRP, ESR, Albumin

Full Text:

PDF

References


HARRISON’S principles of internal medicine 17th edition.

Mazlam MZ, Hodgson HJ. Peripheral blood monocyte cytokine production and acute phase response in inflammatory bowel disease. Gut 1992;33:773–8.

Fiocchi C: Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115:182, 1998)

Veloso FT, Carvalho J, Magro F: Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. J Clin Gastroenterol 23:29, 1996).

Danzi JT: Extraintestinal manifestations of idiopathic inflammatory bowel disease. Arch Intern Med 148:297, 1988)

Sleisenger and Fordtran’s gastrointestinal and liver disease 8 th edition p.2459 – 2548

Shepherd HA, Barr GD, Jewell DP: Use of an intravenous steroid regimen in the treatment of acute Crohn's disease. J Clin Gastroenterol 8:154, 1986

Feagan BG, Rochon J, Fedorak RN, et al: Methotrexate for the treatment of Crohn's disease. The North American Crohn's Study Group Investigators. N Engl J Med 332:292, 1995

Sachar DB, Luppescu NE, Bodian C, et al. Erythrocyte sedimentation as a measure of Crohn’s disease activity: opposite trends in ileitis versus colitis. J Clin Gastroenterol 1990;12:643–6.

Laboratory markers in IBD: useful, magic, or unnecessary toys? GUT 2006;55 ;426 – 431.

Biological Activity Markers in Inflammatory Bowel Disease; D.Desai; W.A. Faubion; W. J. Sandborn ; Aliment Pharmcol. 2007;25(3):247-255.

Performance of blood tests in inflammatory bowel disease ; ADC. BMJ 2004:89;69-71.

Clinical Trials and Therapeutics Assessment of Disease Activity in Ulcerative Colitis and Crohn’s Disease Humphrey J. F. Hodgson and Mansoor Bhatti; Inflammatory Bowel Diseases 1:117-134 0 1995 Crohn’s & Colitis Foundation of America, Inc.


Refbacks

  • There are currently no refbacks.